SG11202105231UA - Pharmaceutical composition for treating wounds - Google Patents
Pharmaceutical composition for treating woundsInfo
- Publication number
- SG11202105231UA SG11202105231UA SG11202105231UA SG11202105231UA SG11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA SG 11202105231U A SG11202105231U A SG 11202105231UA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- treating wounds
- wounds
- treating
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020180146287A KR102668789B1 (en) | 2018-11-23 | 2018-11-23 | Pharmaceutical Composition for Treatment of Wounds |
| PCT/KR2019/016011 WO2020106074A1 (en) | 2018-11-23 | 2019-11-21 | Pharmaceutical composition for treating cuts |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202105231UA true SG11202105231UA (en) | 2021-06-29 |
Family
ID=70773904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202105231UA SG11202105231UA (en) | 2018-11-23 | 2019-11-21 | Pharmaceutical composition for treating wounds |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220008463A1 (en) |
| EP (1) | EP3884952A4 (en) |
| JP (1) | JP7309872B2 (en) |
| KR (1) | KR102668789B1 (en) |
| CN (1) | CN113194965A (en) |
| AU (1) | AU2019383263B2 (en) |
| SG (1) | SG11202105231UA (en) |
| WO (1) | WO2020106074A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102363366B1 (en) * | 2018-11-23 | 2022-02-16 | (주)메디코스바이오텍 | Composition for Treating Alopecia or Stimulating Hair Growth |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60245412A (en) | 1984-05-18 | 1985-12-05 | 株式会社日立製作所 | Gas insulated switching device |
| US4957742A (en) * | 1984-11-29 | 1990-09-18 | Regents Of The University Of Minnesota | Method for promoting hair growth |
| FR2649888B1 (en) | 1989-07-18 | 1994-08-26 | Exsymol Sa | PRODUCTS FOR SKIN APPLICATIONS, WITH COSMETIC OR / AND THERAPEUTIC EFFECTS |
| US5183805A (en) | 1990-08-13 | 1993-02-02 | Board Of Regents, The University Of Texas System | Bioactive egf peptides for promotion of tissue regeneration and cancer therapy |
| US5981606A (en) | 1991-03-01 | 1999-11-09 | Warner-Lambert Company | Therapeutic TGF-beta-wound healing compositions and methods for preparing and using same |
| US5149691A (en) | 1991-03-12 | 1992-09-22 | Creative Biomolecules, Inc. | Issue repair and regeneration through the use of platelet derived growth factor (pdgf) in combination with dexamethasone |
| GB9225581D0 (en) | 1992-12-08 | 1993-01-27 | Courtaulds Plc | Wound dressings |
| US5519020A (en) | 1994-10-28 | 1996-05-21 | The University Of Akron | Polymeric wound healing accelerators |
| WO1996030038A1 (en) | 1995-03-29 | 1996-10-03 | The Rockefeller University | Peptide growth factor having epidermal inducing activity |
| US5897880A (en) | 1995-09-29 | 1999-04-27 | Lam Pharmaceuticals, Llc. | Topical drug preparations |
| US6165978A (en) | 1997-12-12 | 2000-12-26 | University Of Southern California | Wound healing composition |
| IL136583A0 (en) | 1998-10-23 | 2001-06-14 | Polyheal Ltd | Compositions of microspheres for wound healing |
| KR100315168B1 (en) | 1999-01-28 | 2001-11-30 | 대한민국(관리청:특허청장, 승계청:농촌진흥청장) | Preparation of silk fibroin sponge membrane for wound covering materials |
| US20050142208A1 (en) * | 2002-05-09 | 2005-06-30 | Won Min Yoo | Pharmceutical composition for treatment of wounds conntaining blood plasma or serum |
| US20040197319A1 (en) * | 2003-03-24 | 2004-10-07 | Paul Harch | Wound healing composition derived from low platelet concentration plasma |
| US20060142198A1 (en) * | 2004-07-02 | 2006-06-29 | Wound Care Partners Llc | Compositions for treating wounds and processes for their preparation |
| KR20070113876A (en) * | 2006-05-26 | 2007-11-29 | 메디제네스(주) | A pharmaceutical composition for treatment of wounds containing blood plasma component |
| JP5250548B2 (en) * | 2006-06-21 | 2013-07-31 | エムユーエスシー ファウンデーション フォー リサーチ ディベロップメント | Targeting complement factor H for the treatment of disease |
| KR101317420B1 (en) * | 2010-03-11 | 2013-10-10 | 한국과학기술원 | High Molecular Weight Recombinant Silk or Silk-like Proteins and Micro or Nano-spider Silk or Silk-like Fibres Manufactured by Using the Same |
| US8986380B2 (en) * | 2010-06-09 | 2015-03-24 | Trustees Of Tufts College | Multilayered silk scaffolds for meniscus tissue engineering |
| WO2015048344A2 (en) | 2013-09-27 | 2015-04-02 | Tufts University | Silk/platelet composition and use thereof |
| KR20150061806A (en) * | 2013-11-28 | 2015-06-05 | 중부대학교 | Veterinary composition for wound healing of animal containing activated platelet rich plasma |
| KR101617075B1 (en) | 2014-01-24 | 2016-04-29 | 충남대학교산학협력단 | Silk fibroin wound dressing materials and manufacturing method thereof |
| US20170354754A1 (en) * | 2016-06-10 | 2017-12-14 | Brock Liden | Systems and methods for treating a wound with wound packing |
-
2018
- 2018-11-23 KR KR1020180146287A patent/KR102668789B1/en active IP Right Grant
-
2019
- 2019-11-21 SG SG11202105231UA patent/SG11202105231UA/en unknown
- 2019-11-21 US US17/296,301 patent/US20220008463A1/en active Pending
- 2019-11-21 CN CN201980083434.3A patent/CN113194965A/en active Pending
- 2019-11-21 AU AU2019383263A patent/AU2019383263B2/en active Active
- 2019-11-21 JP JP2021529098A patent/JP7309872B2/en active Active
- 2019-11-21 WO PCT/KR2019/016011 patent/WO2020106074A1/en unknown
- 2019-11-21 EP EP19888039.5A patent/EP3884952A4/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20200060997A (en) | 2020-06-02 |
| AU2019383263B2 (en) | 2022-09-29 |
| EP3884952A1 (en) | 2021-09-29 |
| EP3884952A4 (en) | 2022-08-03 |
| JP7309872B2 (en) | 2023-07-18 |
| CN113194965A (en) | 2021-07-30 |
| AU2019383263A1 (en) | 2021-07-08 |
| WO2020106074A1 (en) | 2020-05-28 |
| US20220008463A1 (en) | 2022-01-13 |
| JP2022513123A (en) | 2022-02-07 |
| KR102668789B1 (en) | 2024-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3431105T3 (en) | Medicinal composition for treating cancer | |
| IL280413A (en) | Bismuth-thiol compositions and methods for treating wounds | |
| IL261774B (en) | Compositions for treating dermatological conditions | |
| ZA201803320B (en) | Pharmaceutical compositions for treating pain | |
| IL289213A (en) | Pharmaceutical composition for treating tumor | |
| EP3378491A4 (en) | Pharmaceutical composition for treatment or prophylaxis of nash | |
| IL275525A (en) | Pharmaceutical composition for the treatment of cancer | |
| EP3275450A4 (en) | Pharmaceutical composition for preventing or treating inflammatory diseases, containinglactococcus chungangensis | |
| HK1232128A1 (en) | Pharmaceutical composition for preventing or treating skin rash | |
| EP3375443A4 (en) | Pharmaceutical composition for treating respiratory diseases | |
| KR101894521B9 (en) | Topical pharmaceutical composition for treating scar | |
| EP3354284A4 (en) | Composition for treating pain | |
| EP3831410A4 (en) | Pharmaceutical composition for treating b cell lybphoma | |
| SG11202105231UA (en) | Pharmaceutical composition for treating wounds | |
| IL284181A (en) | Products for treating bleeding wounds | |
| HUE051563T2 (en) | Pharmaceutical composition for preventing or treating cancer | |
| KR102324922B9 (en) | Pharmaceutical composition comprising osteocalcin for preventing or treating inflammatory diseases | |
| PL3773641T3 (en) | Topical pharmaceutical compositions for treating skin conditions | |
| EP3461490C0 (en) | Pharmaceutical composition for treating hemorrhoidal disaese | |
| SG11201913808SA (en) | Pharmaceutical composition for preventing or treating osteoarthritis | |
| KR102316726B9 (en) | Medicinal composition for treating wound | |
| EP3993801A4 (en) | Pharmaceutical composition for treating insomnia | |
| ZA201805489B (en) | Debriding composition for treating wounds | |
| EP3782603C0 (en) | Pharmaceutical composition for treating gout | |
| ZA202202798B (en) | Pharmaceutical composition for topical wound treatment |